Literature DB >> 6736871

Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.

E S Vitetta, R J Fulton, J W Uhr.   

Abstract

In vitro killing of the human Daudi cell line by either univalent [F(ab')] or divalent (IgG) forms of rabbit anti-human Ig (RAHIg) coupled to ricin A chain can be specifically potentiated by a "piggyback" treatment with ricin B chain coupled to goat anti-rabbit Ig (GARIg). When cells are treated with univalent immunotoxin (IT) [F(ab') RAHIg-A] and then cultured, IT can be detected on the cell surface for at least 5 h, since GARIg-B can still enhance killing at this time. These results provide a strategy for in vivo use of A chain- and B chain-containing IT.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736871      PMCID: PMC2187422          DOI: 10.1084/jem.160.1.341

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents.

Authors:  M W Fanger; D A Hart; J V Wells; A Nisonoff
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

2.  Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Authors:  C R Merril; D Goldman; S A Sedman; M H Ebert
Journal:  Science       Date:  1981-03-27       Impact factor: 47.728

3.  Preparation of antibody (IgG)-ricin A-chain conjugate and its biologic activity.

Authors:  H Miyazaki; M Beppu; T Terao; T Osawa
Journal:  Gan       Date:  1980-12

4.  Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells.

Authors:  D T Achord; F E Brot; C E Bell; W S Sly
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

Review 5.  Neoplastic B cells as targets for antibody-ricin A chain immunotoxins.

Authors:  E S Vitetta; K A Krolick; J W Uhr
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 6.  The preparation and cytotoxic properties of antibody-toxin conjugates.

Authors:  P E Thorpe; W C Ross
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 7.  Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy.

Authors:  D M Neville; R J Youle
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 8.  Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity.

Authors:  F K Jansen; H E Blythman; D Carrière; P Casellas; O Gros; P Gros; J C Laurent; F Paolucci; B Pau; P Poncelet; G Richer; H Vidal; G A Voisin
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

9.  Target-cell cytotoxicity of a hybrid of Fab' on immunoglobulin and A-chain of ricin.

Authors:  Y Masuho; T Hara
Journal:  Gan       Date:  1980-12

10.  Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.

Authors:  V Raso; T Griffin
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

View more
  14 in total

1.  A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.

Authors:  K Mujoo; R A Reisfeld; L Cheung; M G Rosenblum
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  Monoclonal antibody targeting of anti-cancer agents.

Authors:  R W Baldwin; V S Byers
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.

Authors:  E J Wawrzynczak; G J Watson; A J Cumber; R V Henry; G D Parnell; E P Rieber; P E Thorpe
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Cloning and expression of recombinant, functional ricin B chain.

Authors:  M S Chang; D W Russell; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 5.  Immunotoxins against solid tumors.

Authors:  R Pirker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 6.  Enhancement of immunotoxin activity using chemical and biological reagents.

Authors:  M Wu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  An ineffective monoclonal antibody-ricin A chain conjugate is converted to a tumouricidal agent in vivo by subsequent systemic administration of ricin B chain.

Authors:  S A Eccles; D P McIntosh; H P Purvies; A J Cumber; G D Parnell; J A Forrester; J M Styles; C J Dean
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.

Authors:  M J Embleton; A Charleston; R A Robins; M V Pimm; R W Baldwin
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

Review 10.  Drug-targeting by monoclonal antibodies.

Authors:  M J Embleton
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.